Literature DB >> 2932464

Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types.

D Sompolinsky, Z Samra, W W Karakawa, W F Vann, R Schneerson, Z Malik.   

Abstract

The relationship of capsular types of Staphylococcus aureus to type of infection, carrier state, and phage type was studied in a collection of 477 isolates from 380 infection sites. Capsular polysaccharides were demonstrated by precipitation and agglutination with 11 monospecific antisera. When only one isolate from each infection was considered, 63% were of type 8 and 16% were of type 5. Of all the isolates tested, over 90% were encapsulated. We did not demonstrate any marked difference in the distribution of capsular types between isolates from the blood stream or purulent processes and isolates from healthy carriers or food. Most isolates from bovine mastitis milk had nontypeable capsules. The capsular type seemed stable in culture, and encapsulation had no apparent influence on susceptibility to phages. Of 27 phage-propagating strains maintained via culture transfer on artificial media over many years, 16 (59%) produced capsules. A striking association between certain phage patterns and capsular types was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932464      PMCID: PMC268536          DOI: 10.1128/jcm.22.5.828-834.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Inhibition of phage infection by pneumococcus capsule.

Authors:  H P Bernheimer; J G Tiraby
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

2.  Staphylococcus aureus cell surface: capsule as a barrier to bacteriophage adsorption.

Authors:  B J Wilkinson; K M Holmes
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Comparative metabolism of virulent and avirulent staphylococci.

Authors:  D Ivler
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

4.  Staphylococcus aureus: cellular biology and clinical application.

Authors:  M H Kaplan; M J Tenenbaum
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

Review 5.  Vaginal colonization with Staphylococcus aureus in healthy women: a review of four studies.

Authors:  M E Guinan; B B Dan; R J Guidotti; A L Reingold; G P Schmid; E J Bettoli; J G Lossick; K N Shands; M A Kramer; N T Hargrett; R L Anderson; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

6.  Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide.

Authors:  J M Fournier; W F Vann; W W Karakawa
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Septicemia with two distinct strains of Staphylococcus aureus and dwarf variants of both.

Authors:  D Sompolinsky; D Schwartz; Z Samra; J Steinmetz; Y Siegman-Igra
Journal:  Isr J Med Sci       Date:  1985-05

8.  Association of high levels of serum antibody to staphylococcal toxic shock antigen with nasal carriage of toxic shock antigen-producing strains of Staphylococcus aureus.

Authors:  H L Ritz; J J Kirkland; G G Bond; E K Warner; G P Petty
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

9.  Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells.

Authors:  R Aly; H R Shinefield; C Litz; H I Maibach
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

10.  Lysogenic pneumococci and their bacteriophages.

Authors:  H P Bernheimer
Journal:  J Bacteriol       Date:  1979-05       Impact factor: 3.490

View more
  86 in total

1.  Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates.

Authors:  S Boyle-Vavra; S K Berke; J C Lee; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.

Authors:  S Ouyang; S Sau; C Y Lee
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

3.  Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.

Authors:  D O Sordelli; F R Buzzola; M I Gomez; L Steele-Moore; D Berg; E Gentilini; M Catalano; A J Reitz; T Tollersrud; G Denamiel; P Jeric; J C Lee
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO(2).

Authors:  S Herbert; S W Newell; C Lee; K P Wieland; B Dassy; J M Fournier; C Wolz; G Döring
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

5.  MsaB activates capsule production at the transcription level in Staphylococcus aureus.

Authors:  Justin L Batte; Dhritiman Samanta; Mohamed O Elasri
Journal:  Microbiology       Date:  2016-01-18       Impact factor: 2.777

6.  Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis.

Authors:  Jai-Wei Lee; Celia N O'Brien; Albert J Guidry; Max J Paape; Kimberley A Shafer-Weaver; X Zhao
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

7.  Chemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus.

Authors:  J C Lee; F Michon; N E Perez; C A Hopkins; G B Pier
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Evaluation of capsular and acapsular strains of S. aureus in an experimental brain abscess model.

Authors:  Nilufer Esen; Gail Wagoner; Napoleon Philips
Journal:  J Neuroimmunol       Date:  2009-11-10       Impact factor: 3.478

9.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  S Xu; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.